• About
    • About Sutro
    • Patient Resources
    • Partnerships
    • Corporate Presentation
  • Leadership
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
  • Technology
    • XpressCF® and XpressCF+™ Platforms
    • Antibody-Drug Conjugates and IADCs
    • Bispecific and Engineered Antibodies
    • cGMP Facility
  • Investors
    • Company Presentation
    • Stock
    • Financials
    • Governance
    • Contact IR
    • Email Alerts
  • Pipeline
  • News
    • News Releases
    • Clinical / Scientific Presentation and Publication Highlights
    • Events
    • Events Audio Replays
  • Careers and Culture
    • The Way We Work
    • Join Our Team
    • Diversity, Inclusion and Social Justice
    • Internships
    • Sutroites
  • Contact Us

American Association for Cancer Research (AACR) Virtual Annual Meeting 2020 – STRO-002 Abstract

by Asa Elmore | Apr 27, 2020 | News, Presentations

American Association for Cancer Research (AACR) Virtual Annual Meeting 2020 – STRO-002 Abstract STRO-002-GM1, a first in human, phase 1 Study of STRO-002, an anti-Folate Receptor alpha (FRα) Antibody Drug Conjugate (ADC), in Patients with Advanced...

Sutro Biopharma to Host Conference Call on April 27, 2020, to Provide Clinical Update on its STRO-002 Antibody-Drug Conjugate

by Asa Elmore | Apr 20, 2020 | Events, News, Presentations, Press Releases

Sutro Biopharma to Host Conference Call on April 27, 2020, to Provide Clinical Update on its STRO-002 Antibody-Drug Conjugate -Company to present updated STRO-002 data at AACR Virtual Annual Meeting – SOUTH SAN FRANCISCO, Calif., April 20, 2020 – Sutro...

Sutro Biopharma to Present Updated Clinical Data for its STRO-002 Antibody-Drug Conjugate at the AACR Virtual Annual Meeting on April 27, 2020

by Asa Elmore | Apr 13, 2020 | Events, News, Presentations, Press Releases

Sutro Biopharma to Present Updated Clinical Data for its STRO-002 Antibody-Drug Conjugate at the AACR Virtual Annual Meeting on April 27, 2020 – Company to host a conference call following the presentation – SOUTH SAN FRANCISCO, Calif., April. 13, 2020 –...

Sutro Biopharma to Present at 38th Annual J.P. Morgan Healthcare Conference

by Asa Elmore | Jan 9, 2020 | Events, News, Press Releases

Sutro Biopharma to Present at 38th Annual J.P. Morgan Healthcare Conference SOUTH SAN FRANCISCO, Calif., Jan. 8, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise...

Open Letter From Our CEO

by Asa Elmore | Jan 8, 2020 | News

Open Letter From Our CEO Hi All, For several years I have been troubled by the levels of public antipathy (if not outright scorn) for our industry.  Routinely biotech (not just pharma) is held in low esteem by the American public – effectively on a par with the...
« Older Entries
Next Entries »

Sutro Biopharma

310 Utah Ave Suite 150
South San Francisco, CA 94080
650-392-8412

 

Map

Tweets by @sutrobio

Contact Us

General Inquires:
general@sutrobio.com
Business Inquires:
busdev@sutrobio.com
Investor Relations Inquires:
IR@sutrobio.com 
Careers:
jobs@sutrobio.com

© 2021 Sutro Biopharma, Inc. -- Privacy Policy
  • Follow
  • Follow
  • Follow